SOURCE: ZELTIQ Aesthetics, Inc.

ZELTIQ Aesthetics, Inc.

August 22, 2014 08:30 ET

ZELTIQ Announces 2014 Investor Day

PLEASANTON, CA--(Marketwired - Aug 22, 2014) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer and Patrick F. Williams, Senior Vice President and Chief Financial Officer, will host an investor and analyst day at the Park Hyatt New York in New York, NY on September 18th, 2014 from 10:00 a.m. ET to 12:00 p.m. ET. The event will highlight the Company's long-term growth and profitability profile, additional marketing and expansion plans, R&D pipeline and include an interactive physician panel to discuss the CoolSculpting® technology and the market for non-invasive body contouring.

Event: ZELTIQ Investor Day
Date: September 18, 2014
Time: 10:00 a.m. ET to 12:00 p.m. ET (Registration begins at 9:30 a.m. ET)
Location: Park Hyatt New York - ONYX Room (153 West 57th Street)

Please RSVP to RSVP@zeltiq.com. The Company will issue an additional press release with further details regarding the event.

An audio web cast of the presentation will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.

About ZELTIQ®
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.